As 2022 comes to a close, we look back on five exciting medical advances coming from clinical researchers at Northwell Health and the health system's Feinstein Institutes for Medical Research. In the last year alone, investigators published more than 2,500 papers in peer-reviewed journals. In this episode, we spotlight studies that made strides against endometriosis, diabetes, lupus, pancreatic cancer and (yes) Covid-19.
Read more about these Five notable Northwell advances of 2022.
Chapters:
Meet our guests:
Matthew Weiss, MD, professor in the Institute of Cancer Research at the Feinstein Institutes and the deputy physician-in-chief and surgical director in the Cancer Institute at Northwell Health
Richard Furie, MD, chief of the Division of Rheumatology at Northwell and global principal investigator on the LILAC (Part A) clinical trial
Tobias Janowitz, MD, PhD, assistant professor, Cold Spring Harbor Laboratory; adjunct professor at the Feinstein Institutes; and principal investigator of the trial studying famotidine for Covid
Christine Metz, PhD, professor in the Institute of Molecular Medicine at the Feinstein Institutes and co-director of Research OutSmarts Endometriosis (ROSE) study
Sangeeta Chavan, PhD, professor at the Feinstein Institutes for Medical Research
